NCT02958956View on ClinicalTrials.gov

Cohort Study of Pioglitazone and Cancer Incidence in Participants With Diabetes Mellitus.

CompletedOBSERVATIONAL

Enrollment

236,507

Participants

Timeline

Start Date

January 1, 1997

Primary Completion Date

May 29, 2015

Study Completion Date

May 29, 2015

Conditions

Diabetes Mellitus, Type 2, Cancer

Interventions

DRUG

Pioglitazone

Participants with diabetes who were members of the KPNC registry, and had received at least 2 prescriptions for pioglitazone within a 6-month period were followed up to 15.5 years (1997-2012) in this observational study 1.